IP Library › Granted Patent US 12,678,338
Granted Patent B2
US 12,678,338 · App. 17/565,013 · Granted Jul 14, 2026

Tissue healing

Inventors: Samantha Dawn Hartwell (Hull, GB); Donald Anthony Hudson (Claremont, ZA)
Assignee: Smith & Nephew PLC
A61F13/0253A61F13/0206A61F13/022A61F13/0223A61F13/0243A61F13/05A61M1/915A61M1/985A61M1/916
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,678,338
App. No.
17/565,013
Filed
Dec 29, 2021
Granted
Jul 14, 2026
Kind
B2
Art Unit
3781
USPC
604/319
Abstract

A system, method, and apparatus are disclosed for dressing a wound and for minimizing scarring. The apparatus promotes scar-minimizing healing of a wound where negative pressure wound therapy is applied, and comprises a wound contact layer containing silicone, polysiloxanes, or other related compounds.

Claims (30)

1 . An apparatus for promoting scar-free healing at a tissue site, the apparatus comprising:

a tissue contact layer comprising silicone and a plurality of perforations the combined open area of the perforations comprising around 20% or less of the total area of a single side of the tissue contact layer, the silicone in the tissue contact layer comprising a moisture vapor transmission rate of between about 350 to 410 gm −2 /24 hrs when unperforated;

a source of negative pressure connectable to the tissue site and configured to apply negative pressure through the tissue contact layer to a wounded area beneath the tissue contact layer;

wherein the tissue contact layer is configured to reduce transepidermal water loss after negative pressure is applied through the tissue contact layer for a period of time, compared to if the negative pressure is applied at the tissue site without using the tissue contact layer; and

wherein the tissue contact layer is configured to reduce scar tissue formation by at least one point on the Vancouver or Manchester Scar Scale after negative pressure is applied through the tissue contact layer for a period of time sufficient to close the wound, compared to if negative pressure is applied at the tissue site without using said tissue contact layer.

2 . The apparatus of claim 1 , further comprising a transmission layer positioned over the tissue contact layer.

3 . The apparatus of claim 2 , further comprising an absorbent layer configured to absorb wound exudate, the absorbent layer positioned over the transmission layer.

4 . The apparatus of claim 1 , wherein the tissue contact layer comprises a basis weight of about 130 gsm when unperforated.

5 . The apparatus of claim 1 , wherein the tissue contact layer comprises a moisture vapor transmission rate of about 380 gm −2 /24 hrs when unperforated.

6 . The apparatus of claim 1 , further comprising a cover layer comprising a fluid passage.

7 . The apparatus of claim 1 , wherein the silicone comprises polysiloxane, polyorganosiloxane, or polydimethylsiloxane.

8 . The apparatus of claim 1 , wherein the combined area of the apertures comprises about 17.5% or less of the total area of a single side of the tissue contact layer.

9 . An apparatus for promoting scar-free healing at a tissue site, the apparatus comprising:

a tissue contact layer comprising silicone and a plurality of perforations, individual perforations comprising an average diameter of 0.025 mm to 1.5 mm, the combined open area of the perforations comprising around 20% or less of the total area of a single side of the tissue contact layer;

a source of negative pressure connectable to the tissue site and configured to apply negative pressure through the tissue contact layer to a wounded area beneath the tissue contact layer;

wherein the silicone comprises polysiloxane, polyorganosiloxane, or polydimethylsiloxane; and

wherein the tissue contact layer is configured to reduce scar tissue formation by at least one point on the Vancouver or Manchester Scar Scale after negative pressure is applied through the tissue contact layer for a period of time sufficient to close the wound, compared to if negative pressure is applied at the tissue site without using said tissue contact layer.

10 . The apparatus of claim 9 , further comprising a transmission layer positioned over the tissue contact layer.

11 . The apparatus of claim 10 , further comprising an absorbent layer configured to absorb wound exudate, the absorbent layer positioned over the transmission layer.

12 . The apparatus of claim 9 , further comprising a cover layer comprising a fluid passage.

13 . The apparatus of claim 9 , wherein the combined area of the apertures comprises about 17.5% or less of the total area of a single side of the tissue contact layer.

14 . An apparatus for promoting scar-free healing at a tissue site where negative pressure is applied, the apparatus comprising:

a tissue contact layer comprising silicone and a plurality of perforations, the combined open area of the perforations comprising about 20% or less of the total area of a single side of the tissue contact layer;

a source of negative pressure connectable to the tissue site and configured to apply negative pressure through the tissue contact layer to a wounded area beneath the tissue contact layer;

a transmission layer positioned over the tissue contact layer, the transmission layer configured to distribute negative pressure; and

a cover layer positioned over the transmission layer, the cover layer comprising an opening, the opening configured to connect to the source of negative pressure; and

wherein the tissue contact layer is configured to reduce scar tissue formation by at least one point on the Vancouver or Manchester Scar Scale after negative pressure is applied through the tissue contact layer for a period of time sufficient to close the wound, compared to if negative pressure is applied at the tissue site without using said tissue contact layer.

15 . The apparatus of claim 14 , wherein individual perforations comprise an average diameter of 0.025 mm to 1.5 mm.

16 . The apparatus of claim 14 , wherein the silicone comprises polysiloxane, polyorganosiloxane, or polydimethylsiloxane.

17 . The apparatus of claim 14 , wherein the combined open area of the apertures comprises about 17.5% or less of the total area of a single side of the tissue contact layer.

Priority Claims (1)
GB 1108229 · May 17, 2011 · national
Continuity (3)
Continuation 16357158 · Mar 18, 2019
Continuation 14118202 · Nov 2, 2011
Related Publication 20220192886A1 · Jun 23, 2022
References Cited (355)
US 3459618A · Egler · 1969 [cited by examiner]
US 3645835A · Hodgson · 1972 [cited by applicant]
US 3908650A · Dunshee et al. · 1975 [cited by applicant]
US 3972328A · Chen · 1976 [cited by applicant]
US 4029598A · Neisius et al. · 1977 [cited by applicant]
US 4595001A · Potter et al. · 1986 [cited by applicant]
US 4728499A · Fehder · 1988 [cited by applicant]
US 4743249A · Loveland · 1988 [cited by applicant]
US 4798201A · Rawlings et al. · 1989 [cited by applicant]
US 4813942A · Alvarez · 1989 [cited by applicant]
US 5010883A · Rawlings et al. · 1991 [cited by applicant]
US 5056510A · Gilman · 1991 [cited by applicant]
US 5181905A · Flam · 1993 [cited by applicant]
US 5238732A · Krishnan · 1993 [cited by applicant]
US 5340363A · Fabo · 1994 [cited by applicant]
US 5549584A · Gross · 1996 [cited by applicant]
US 5641506A · Talke et al. · 1997 [cited by applicant]
US 5707499A · Joshi et al. · 1998 [cited by applicant]
US 5759570A · Arnold · 1998 [cited by applicant]
US 5852126A · Barnard et al. · 1998 [cited by applicant]
US 5910125A · Cummings et al. · 1999 [cited by applicant]
US 6071267A · Zamierowski · 2000 [cited by applicant]
US 6277224B1 · Muesch et al. · 2001 [cited by applicant]
US 6345623B1 · Heaton et al. · 2002 [cited by applicant]
US 6495229B1 · Carte et al. · 2002 [cited by applicant]
US 6626891B2 · Ohmstede · 2003 [cited by applicant]
US 6685681B2 · Lockwood et al. · 2004 [cited by applicant]
US 6752794B2 · Lockwood et al. · 2004 [cited by applicant]
US 6903243B1 · Burton · 2005 [cited by applicant]
US 6936037B2 · Bubb et al. · 2005 [cited by applicant]
US 6951553B2 · Bubb et al. · 2005 [cited by applicant]
US 6979324B2 · Bybordi et al. · 2005 [cited by applicant]
US 7004915B2 · Boynton et al. · 2006 [cited by applicant]
US 7070584B2 · Johnson et al. · 2006 [cited by applicant]
US 7108683B2 · Zamierowski · 2006 [cited by applicant]
US 7216651B2 · Argenta et al. · 2007 [cited by applicant]
US 7361184B2 · Joshi · 2008 [cited by applicant]
US 7381859B2 · Hunt et al. · 2008 [cited by applicant]
US 7569742B2 · Haggstrom et al. · 2009 [cited by applicant]
US 7605298B2 · Bechert et al. · 2009 [cited by applicant]
US 7615036B2 · Joshi et al. · 2009 [cited by applicant]
US 7622629B2 · Aali · 2009 [cited by applicant]
US 7625362B2 · Boehringer et al. · 2009 [cited by applicant]
US 7699823B2 · Haggstrom et al. · 2010 [cited by applicant]
US 7700819B2 · Ambrosio et al. · 2010 [cited by applicant]
US 7708724B2 · Weston · 2010 [cited by applicant]
US 7718249B2 · Russell et al. · 2010 [cited by applicant]
US 7722582B2 · Lina et al. · 2010 [cited by applicant]
US 7749531B2 · Booher · 2010 [cited by applicant]
US 7759537B2 · Bishop et al. · 2010 [cited by applicant]
US 7759539B2 · Shaw et al. · 2010 [cited by applicant]
US 7775998B2 · Riesinger · 2010 [cited by applicant]
US 7779625B2 · Joshi et al. · 2010 [cited by applicant]
US 7811269B2 · Boynton et al. · 2010 [cited by applicant]
US 7838717B2 · Haggstrom et al. · 2010 [cited by applicant]
US 7846141B2 · Weston · 2010 [cited by applicant]
US 7910791B2 · Coffey · 2011 [cited by applicant]
US 7922703B2 · Riesinger · 2011 [cited by applicant]
US 7959624B2 · Riesinger · 2011 [cited by applicant]
US 7964766B2 · Blott et al. · 2011 [cited by applicant]
US 7976519B2 · Bubb et al. · 2011 [cited by applicant]
US 8034037B2 · Adams et al. · 2011 [cited by applicant]
US 8062272B2 · Weston · 2011 [cited by applicant]
US 8062331B2 · Zamierowski · 2011 [cited by applicant]
US 8080702B2 · Blott et al. · 2011 [cited by applicant]
US 8118794B2 · Weston · 2012 [cited by applicant]
US 8152785B2 · Vitaris · 2012 [cited by applicant]
US 8162907B2 · Heagle · 2012 [cited by applicant]
US 8207392B2 · Haggstrom et al. · 2012 [cited by applicant]
US 8235972B2 · Adahan · 2012 [cited by applicant]
US 8241261B2 · Randolph et al. · 2012 [cited by applicant]
US 8282611B2 · Weston · 2012 [cited by applicant]
US 8303552B2 · Weston · 2012 [cited by applicant]
US 8372049B2 · Jaeb et al. · 2013 [cited by applicant]
US 8372050B2 · Jaeb et al. · 2013 [cited by applicant]
US 8425478B2 · Olson · 2013 [cited by applicant]
US 8444612B2 · Patel et al. · 2013 [cited by applicant]
US 8460255B2 · Joshi et al. · 2013 [cited by applicant]
US 8540688B2 · Eckstein et al. · 2013 [cited by applicant]
US 8545466B2 · Andresen et al. · 2013 [cited by applicant]
US 8568386B2 · Malhi · 2013 [cited by applicant]
US 8628505B2 · Weston · 2014 [cited by applicant]
US 8641691B2 · Fink et al. · 2014 [cited by applicant]
US 8663198B2 · Buan et al. · 2014 [cited by applicant]
US 8715256B2 · Greener · 2014 [cited by applicant]
US 8764732B2 · Hartwell · 2014 [cited by applicant]
US 8777911B2 · Heagle · 2014 [cited by examiner]
US 8795243B2 · Weston · 2014 [cited by applicant]
US 8795800B2 · Evans · 2014 [cited by applicant]
US 8808274B2 · Hartwell · 2014 [cited by applicant]
US 8829263B2 · Haggstrom et al. · 2014 [cited by applicant]
US 8834451B2 · Blott et al. · 2014 [cited by applicant]
US 8834452B2 · Hudspeth et al. · 2014 [cited by applicant]
US 8956336B2 · Haggstrom et al. · 2015 [cited by applicant]
US 9061095B2 · Adie et al. · 2015 [cited by applicant]
US 9067003B2 · Buan et al. · 2015 [cited by applicant]
US 9127665B2 · Locke et al. · 2015 [cited by applicant]
US 9168330B2 · Joshi et al. · 2015 [cited by applicant]
US 9199012B2 · Vitaris et al. · 2015 [cited by applicant]
US 9220822B2 · Hartwell · 2015 [cited by applicant]
US 9283118B2 · Locke et al. · 2016 [cited by applicant]
US 9302033B2 · Riesinger · 2016 [cited by applicant]
US 9375353B2 · Vitaris et al. · 2016 [cited by applicant]
US 9375521B2 · Hudspeth et al. · 2016 [cited by applicant]
US 9381283B2 · Adams et al. · 2016 [cited by applicant]
US 9452248B2 · Blott et al. · 2016 [cited by applicant]
US 9474654B2 · Heagle · 2016 [cited by examiner]
US 9597489B2 · Heagle · 2017 [cited by applicant]
US 9669138B2 · Joshi et al. · 2017 [cited by applicant]
US 9682179B2 · May · 2017 [cited by applicant]
US 9795725B2 · Joshi et al. · 2017 [cited by applicant]
US 9808561B2 · Adie et al. · 2017 [cited by applicant]
US 9844475B2 · Hartwell · 2017 [cited by examiner]
US 9907703B2 · Allen · 2018 [cited by examiner]
US 9956121B2 · Hartwell · 2018 [cited by examiner]
US 10123909B2 · Hartwell · 2018 [cited by examiner]
US 11129751B2 · Hartwell · 2021 [cited by examiner]
US 20010020146A1 · Satterfield et al. · 2001 [cited by applicant]
US 20020082567A1 · Lockwood et al. · 2002 [cited by applicant]
US 20030125646A1 · Whitlock · 2003 [cited by applicant]
US 20040057855A1 · Gerlach et al. · 2004 [cited by applicant]
US 20040126413A1 · Sigurjonsson et al. · 2004 [cited by applicant]
US 20050154340A1 · Schlussel · 2005 [cited by applicant]
US 20060009744A1 · Erdman et al. · 2006 [cited by applicant]
US 20060079852A1 · Bubb et al. · 2006 [cited by applicant]
US 20070040454A1 · Freudenberger et al. · 2007 [cited by applicant]
US 20070055209A1 · Patel et al. · 2007 [cited by applicant]
US 20070225663A1 · Watt et al. · 2007 [cited by applicant]
US 20070255194A1 · Gudnason et al. · 2007 [cited by applicant]
US 20080031748A1 · Ihle et al. · 2008 [cited by applicant]
US 20080132821A1 · Propp et al. · 2008 [cited by applicant]
US 20080167593A1 · Fleischmann · 2008 [cited by applicant]
US 20080223378A1 · Henderson et al. · 2008 [cited by applicant]
US 20080233348A1 · Ishiwatari et al. · 2008 [cited by applicant]
US 20080255493A1 · Sigurjonsson et al. · 2008 [cited by applicant]
US 20080306456A1 · Riesinger · 2008 [cited by applicant]
US 20090125004A1 · Shen et al. · 2009 [cited by applicant]
US 20090157024A1 · Song · 2009 [cited by applicant]
US 20090192475A1 · Siegel · 2009 [cited by applicant]
US 20090216170A1 · Robinson et al. · 2009 [cited by applicant]
US 20090227969A1 · Jaeb et al. · 2009 [cited by applicant]
US 20090234306A1 · Vitaris · 2009 [cited by applicant]
US 20090234309A1 · Vitaris et al. · 2009 [cited by applicant]
US 20090240185A1 · Jaeb et al. · 2009 [cited by applicant]
US 20090254053A1 · Svensby et al. · 2009 [cited by applicant]
US 20090299251A1 · Buan · 2009 [cited by applicant]
US 20090299306A1 · Buan · 2009 [cited by applicant]
US 20100030170A1 · Keller et al. · 2010 [cited by applicant]
US 20100030178A1 · Macmeccan et al. · 2010 [cited by applicant]
US 20100125258A1 · Coulthard et al. · 2010 [cited by applicant]
US 20100159192A1 · Cotton · 2010 [cited by applicant]
US 20100179463A1 · Greener et al. · 2010 [cited by applicant]
US 20100210986A1 · Sanders et al. · 2010 [cited by applicant]
US 20100259406A1 · Caso et al. · 2010 [cited by applicant]
US 20100262090A1 · Riesinger · 2010 [cited by applicant]
US 20100262091A1 · Larsson · 2010 [cited by applicant]
US 20100268198A1 · Buan et al. · 2010 [cited by applicant]
US 20100305490A1 · Coulthard et al. · 2010 [cited by applicant]
US 20100305526A1 · Robinson et al. · 2010 [cited by applicant]
US 20100318052A1 · Ha et al. · 2010 [cited by applicant]
US 20100324510A1 · Andresen et al. · 2010 [cited by applicant]
US 20110004172A1 · Eckstein et al. · 2011 [cited by applicant]
US 20110028918A1 · Hartwell · 2011 [cited by applicant]
US 20110028919A1 · Johnnison et al. · 2011 [cited by applicant]
US 20110033515A1 · Harpstead et al. · 2011 [cited by applicant]
US 20110054421A1 · Hartwell · 2011 [cited by applicant]
US 20110054422A1 · Locke et al. · 2011 [cited by applicant]
US 20110112492A1 · Bharti · 2011 [cited by examiner]
US 20110118683A1 · Weston · 2011 [cited by applicant]
US 20110160686A1 · Ueda et al. · 2011 [cited by applicant]
US 20110172612A1 · Greener et al. · 2011 [cited by applicant]
US 20110224631A1 · Simmons et al. · 2011 [cited by applicant]
US 20110257572A1 · Locke et al. · 2011 [cited by applicant]
US 20110282309A1 · Adie et al. · 2011 [cited by applicant]
US 20120029455A1 · Perez-Foullerat et al. · 2012 [cited by applicant]
US 20120041399A1 · Blott et al. · 2012 [cited by applicant]
US 20120041402A1 · Greener · 2012 [cited by applicant]
US 20120051945A1 · Orndorff et al. · 2012 [cited by applicant]
US 20120058289A1 · Coates et al. · 2012 [cited by applicant]
US 20120095380A1 · Gergely et al. · 2012 [cited by applicant]
US 20120123220A1 · Lyer · 2012 [cited by examiner]
US 20120232502A1 · Lowing · 2012 [cited by applicant]
US 20130066285A1 · Locke et al. · 2013 [cited by applicant]
US 20130066289A1 · Song et al. · 2013 [cited by applicant]
US 20130090616A1 · Neubauer · 2013 [cited by applicant]
US 20130116635A1 · Fleischmann · 2013 [cited by applicant]
US 20130138054A1 · Fleischmann · 2013 [cited by applicant]
US 20130138060A1 · Haggstrom et al. · 2013 [cited by applicant]
US 20130144230A1 · Wu et al. · 2013 [cited by applicant]
US 20130150814A1 · Buan · 2013 [cited by applicant]
US 20130165878A1 · Heagle · 2013 [cited by applicant]
US 20130274688A1 · Weston · 2013 [cited by applicant]
US 20130296762A1 · Toth · 2013 [cited by applicant]
US 20130302545A1 · Schnelker et al. · 2013 [cited by applicant]
US 20130331822A1 · Patel et al. · 2013 [cited by applicant]
US 20130338613A1 · Haggstrom et al. · 2013 [cited by applicant]
US 20140058309A1 · Addison et al. · 2014 [cited by applicant]
US 20140114268A1 · Auguste et al. · 2014 [cited by applicant]
US 20140142524A1 · Eckstein et al. · 2014 [cited by applicant]
US 20140228791A1 · Hartwell · 2014 [cited by applicant]
US 20140236109A1 · Greener · 2014 [cited by applicant]
US 20140249493A1 · Hartwell · 2014 [cited by applicant]
US 20140316359A1 · Collinson et al. · 2014 [cited by applicant]
US 20140350494A1 · Hartwell et al. · 2014 [cited by applicant]
US 20150032035A1 · Banwell et al. · 2015 [cited by applicant]
US 20150065965A1 · Haggstrom et al. · 2015 [cited by applicant]
US 20150209492A1 · Blott et al. · 2015 [cited by applicant]
US 20150308994A1 · Hammond et al. · 2015 [cited by applicant]
US 20150320605A1 · Pigg et al. · 2015 [cited by applicant]
US 20160081859A1 · Hartwell · 2016 [cited by applicant]
US 20160144084A1 · Collinson et al. · 2016 [cited by applicant]
US 20160298620A1 · Cordoba et al. · 2016 [cited by applicant]
US 20160317357A1 · Vitaris et al. · 2016 [cited by applicant]
US 20170128642A1 · Buan · 2017 [cited by applicant]
US 20170181896A1 · Hartwell · 2017 [cited by applicant]
US 20170181897A1 · Hartwell · 2017 [cited by applicant]
US 20170348154A1 · Robinson et al. · 2017 [cited by applicant]
DE 3443101A1 · 1986 [cited by applicant]
DE 202004017052U1 · 2005 [cited by applicant]
EP 0257916A1 · 1988 [cited by applicant]
EP 0300620A1 · 1989 [cited by applicant]
EP 0340018A2 · 1989 [cited by applicant]
EP 1476217B1 · 2008 [cited by applicant]
EP 1955887A2 · 2008 [cited by applicant]
EP 2021046B1 · 2012 [cited by applicant]
EP 2462908A1 · 2012 [cited by applicant]
EP 2544642B1 · 2015 [cited by applicant]
EP 2648668A4 · 2015 [cited by applicant]
EP 2830555A1 · 2015 [cited by applicant]
EP 2836711A1 · 2015 [cited by applicant]
EP 2837370A1 · 2015 [cited by applicant]
EP 3628289B1 · 2021 [cited by applicant]
FR 1163907A · 1958 [cited by applicant]
FR 2633825A1 · 1990 [cited by applicant]
GB 1255395A · 1971 [cited by applicant]
GB 2307180B · 2000 [cited by applicant]
GB 2468905A · 2010 [cited by applicant]
JP 2010000159A · 2010 [cited by applicant]
WO WO8300742A1 · 1983 [cited by applicant]
WO WO9216245A1 · 1992 [cited by applicant]
WO WO9420041A1 · 1994 [cited by applicant]
WO WO9529959A1 · 1995 [cited by applicant]
WO WO9605873A1 · 1996 [cited by applicant]
WO WO2004006972A1 · 2004 [cited by applicant]
WO WO2004060225A1 · 2004 [cited by applicant]
WO WO2004060359A1 · 2004 [cited by applicant]
WO WO2004077387A1 · 2004 [cited by applicant]
WO WO2004108175A1 · 2004 [cited by applicant]
WO WO2005025447A2 · 2005 [cited by applicant]
WO WO2005046760A1 · 2005 [cited by applicant]
WO WO2005051461A1 · 2005 [cited by applicant]
WO WO2005105180A1 · 2005 [cited by applicant]
WO WO2005123170A1 · 2005 [cited by applicant]
WO WO2006052839A2 · 2006 [cited by applicant]
WO WO2006133430A2 · 2006 [cited by applicant]
WO WO2008039223A1 · 2008 [cited by applicant]
WO WO2008109887A1 · 2008 [cited by applicant]
WO WO2009066105A1 · 2009 [cited by applicant]
WO WO2009082486A1 · 2009 [cited by applicant]
WO WO2009124100A1 · 2009 [cited by applicant]
WO WO2009146441A1 · 2009 [cited by applicant]
WO WO2009147402A2 · 2009 [cited by applicant]
WO WO2009158128A2 · 2009 [cited by applicant]
WO WO2010061228A1 · 2010 [cited by applicant]
WO WO2010122665A1 · 2010 [cited by applicant]
WO WO2010142959A2 · 2010 [cited by applicant]
WO WO2010147533A1 · 2010 [cited by applicant]
WO WO2010147930A1 · 2010 [cited by applicant]
WO WO2011135285A1 · 2011 [cited by applicant]
WO WO2011135286A1 · 2011 [cited by applicant]
WO WO2011135287A1 · 2011 [cited by applicant]
WO WO2011144888A1 · 2011 [cited by applicant]
WO WO2012028842A1 · 2012 [cited by applicant]
WO WO2012034238A1 · 2012 [cited by applicant]
WO WO2012041296A2 · 2012 [cited by applicant]
WO WO2012131237A1 · 2012 [cited by applicant]
WO WO2012140378A1 · 2012 [cited by applicant]
WO WO2012143665A1 · 2012 [cited by applicant]
WO WO2012156655A1 · 2012 [cited by applicant]
WO WO2013010907A1 · 2013 [cited by applicant]
WO WO2013064852A1 · 2013 [cited by applicant]
WO WO2013083800A1 · 2013 [cited by applicant]
WO WO2013090810A1 · 2013 [cited by applicant]
WO WO2013114097A1 · 2013 [cited by applicant]
WO WO2013136181A2 · 2013 [cited by applicant]
WO WO2013149078A1 · 2013 [cited by applicant]
WO WO2014008348A2 · 2014 [cited by applicant]
WO WO2014016759A1 · 2014 [cited by applicant]
WO WO2014020440A1 · 2014 [cited by applicant]
WO WO2014020443A2 · 2014 [cited by applicant]
WO WO2014108476A1 · 2014 [cited by applicant]
WO WO2014113253A1 · 2014 [cited by applicant]
WO WO2014184674A2 · 2014 [cited by applicant]
WO WO2015022334A1 · 2015 [cited by applicant]
WO WO2015022340A1 · 2015 [cited by applicant]
WO WO2015031216A1 · 2015 [cited by applicant]
WO WO2015052225A1 · 2015 [cited by applicant]
Worley, Cynthia A. “So, what do I put on this wound? The wound dressing puzzle: part III.” Dermatol Nurs 17 (2005): 299-300. (Year: 2005). [cited by examiner]
Cubison, T. C., Pape, S. A., & Parkhouse, N. (2006). Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns, 32(8), 992-999. [cited by examiner]
Wilkinson, H. N., Longhorne, F. L., Roberts, E. R., Brownhill, V. R., & Hardman, M. J. (2021). Cellular benefits of single-use negative pressure wound therapy demonstrated in a novel ex vivo human skin wound model. Woun… [cited by examiner]
SSPM823 Thin Silicone Membranes—Specialty Silicone Products, SSPM823 Rev. 5, Nov. 24, 2014. https://sspinc.com/products/ssp-m823/. [cited by examiner]
Benedek I., et al., “Technology of Pressure Sensitive Adhesives and Products,” Chapter 6, 2009, 25 pages. [cited by applicant]
Communication indication Deficiencies in the Notice of Opposition for European Patent No. 2712312, dated Sep. 21, 2023, 6 pages. [cited by applicant]
Communication of a Notice of Opposition including Statement of Facts and Arguments for European Patent No. 2712312, dated Sep. 19, 2023, 18 pages. [cited by applicant]
Decision of Board of Appeal T 0555/18 Datasheet for the decision of Sep. 14, 2022 for European Patent No. 2117839, mailed on Oct. 26, 2022, 22 pages. [cited by applicant]
Declaration of Akagi Keiji for European Patent No. 2712312 dated Oct. 6, 2023, 1 page. [cited by applicant]
KCI, “V.A.C. Therapy Clinical guidelines: A reference source for clinicians,” Jan. 2005, 36 pages. [cited by applicant]
Letter from Opponent regarding the Opposition Procedure for European Patent No. 2712312, dated Sep. 22, 2023, 3 pages. [cited by applicant]
Mustoe T.A., “Evolution of Silicone Therapy and Mechanism of Action in Scar Management”, Aesth Plast Surg 2008, 32:82-92, 11 Pages. [cited by applicant]
Notice of Opposition—Opponent's Statement of Facts and Arguments of the European Patent No. 2712312, dated Oct. 9, 2023, 12 pages. [cited by applicant]
Notice of Opposition—Opponent's Statement of Facts and Arguments of the European Patent No. 2712312, dated Oct. 13, 2023, 29 pages. [cited by applicant]
Notice of Opposition—Opponent's Statement of Facts and Arguments of the European Patent No. 2712312, dated Oct. 16, 2023, 33 pages. [cited by applicant]
Notice of Opposition—Opponent's Statement of Facts and Arguments of the European Patent No. 2712312, dated Oct. 17, 2023, 66 pages. [cited by applicant]
Wikipedia: “Silicone Gel Sheeting”, Sep. 28, 2023, 8 Pages, Retrieved from the Internet: URL: https://en.wikipedia.org/wiki/Silicone_gel_sheeting. [cited by applicant]
BASF., “Thermoplastic Polyurethane Elastomers (TPU),” Elastollan—Product Range, 2016, 40 pages, Retrieved from the Internet: URL: https://www.basf.com/kr/documents/ko/product/Thermoplastic%20Polyurethane_Elastollan_Prod… [cited by applicant]
Abaev J.K., “Handbook of the surgeon, Wounds and wound infection,” Rostov-on-Don, Phoenix, 2006, 433 pages. [cited by applicant]
Acton C., “Use of Mepitel One in Conjunction with Negative Pressure Wound Therapy: A Case Study Series,” 2009, 1 page. [cited by applicant]
Advantec MFS, Inc., “Membrane Filters” (catalog), retrieved from http://www.advantecmfs.com/catalog/filt/membrane.pdf, on Jan. 29, 2016, Copyright 2001-2011, 17 pages. [cited by applicant]
Atiyeh B.S., “Nonsurgical Management of Hypertrophic Scars: Evidence-Based Therapies, Standard Practices, and Emerging Methods,” Aesthetic Plastic Surgery, vol. 31, No. 5, 2007, pp. 468-492. [cited by applicant]
Blakely A.M., “The Innovative Use of Safetac® Soft Silicone in Conjunction with Negative Pressure Wound Therapy: Three Case Studies,” 2007, 1 page. [cited by applicant]
Hersle K., et al., “Uses of Dextranomer Absorbent Pads After Cryosurgery of Cutaneous Malignancies,” The Journal of Dermatologic Surgery and Oncology, vol. 8, Jan. 1982, pp. 35-37. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/GB2011/001553, mailed on Nov. 28, 2013, 11 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/GB2011/001553, mailed on Apr. 12, 2012, 14 pages. [cited by applicant]
Jones S.M., et al., “Interface Dressings Influence the Delivery of Topical Negative-Pressure Therapy,” Plastic and Reconstructive Surgery, Sep. 15, 2005, 6 pages. [cited by applicant]
Kendall ULTEC Hydrocolloid Dressing (4×4″), Product Ordering Page, web page downloaded on Jul. 13, 2014, 1 page. [cited by applicant]
Protz K., “Modern Wound Dressings Support the Healing Process,” Wound care: Indications and Application, Geriatrie Journal, Apr. 2005, pp. 3333-3339 (17 pages with English translation). [cited by applicant]
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System,” Spiral Booklet, Mar. 2011, 7 pages. [cited by applicant]
Technology Watch, May 1989, 1 page. [cited by applicant]
Brief Communication—Letter from the Opponent O2 of Jun. 18, 2024 for European Patent No. 2712312, mailed on Jun. 21, 2024, 17 pages. [cited by applicant]
Brief Communication—Letter from the Opponent O4 of Jun. 4, 2024 for European Patent No. 2712312, mailed on Jun. 7, 2024, 4 pages. [cited by applicant]
Brief Communication—Letter from the Proprietor of the Patent of Mar. 4, 2024 for European Patent No. 2712312, mailed Mar. 11, 2024, 33 pages. [cited by applicant]
Brief Communication—Letter from the Proprietor of the Patent of Mar. 12, 2024 for European Patent No. 2712312, mailed Mar. 15, 2024, 3 pages. [cited by applicant]
Declaration of Dr. Viktoria Skeppstedt filed in the Opposition against European Patent No. 2712312, dated Jun. 13, 2024, 2 pages. [cited by applicant]
Declaration of Victoria Beadle filed in the Opposition against European Patent No. 2712312, dated Mar. 1, 2024, 3 pages. [cited by applicant]
Letter from Opponent regarding the Opposition Procedure for European Patent No. 2712312, dated Mar. 20, 2024, 4 pages. [cited by applicant]
Notice of Communication of Amended Entries concerning the Representative (R. 143(1)(h) EPC) for European Patent No. 2712312, mailed on Mar. 6, 2024, 39 pages. [cited by applicant]
Study Record of “PICO Breast Reduction Clinical Study Looking at Incision Healing Complications”, Smith & Nephew, Inc. (sponsor), ClinicalTrials.gov ID: NCT01640366, last update posted Feb. 28, 2020, 8 pages. URL: https… [cited by applicant]
Brief Communication—Letter from the Proprietor of the Patent of Oct. 14, 2024 for European Patent No. 2712312, mailed Oct. 18, 2024, 6 pages. [cited by applicant]
Brownhill, V. et al., “Pre-Clinical Assessment of Single-Use Negative Pressure Wound Therapy During In Vivo Porcine Wound Healing”, Advances in Wound Care, 2020, vol. 00, No. 00, in 12 pages. [cited by applicant]
Declaration under 37 C.F.R. 1.132 of Samantha Dawn Hartwell dated Jul. 25, 2024, 11 pages. [cited by applicant]
“Unlocking the mechanism of action (MoA) of PICO Single Use Negative Wound Pressure Therapy System (sNPWT)”, Smith+Nephew, 2021, AWM-AWD-29707 | GMC1352, in 36 pages. [cited by applicant]
Annex to the Communication filed in the Opposition against European Patent No. 2712312, mailed on Dec. 3, 2024, 19 pages. [cited by applicant]
Baraboski S., et al., “Wound Care Essentials: Practice Principles,” Lippincott Williams & Wilkins, 2004, 3 pages. [cited by applicant]
Brief Communication—Letter from the Opponent O1 of Aug. 8, 2025 filed in the Opposition against European Patent No. 2712312, dated Aug. 12, 2025, 10 pages. [cited by applicant]
Brief Communication—Letter from the Opponent O2 of Aug. 8, 2025 filed in the Opposition against European Patent No. 2712312, dated Aug. 13, 2025, 18 pages. [cited by applicant]
Brief Communication—Letter from the Opponent O3 of Aug. 8, 2025 filed in the Opposition against European Patent No. 2712312, dated Aug. 13, 2025, 18 pages. [cited by applicant]
Brief Communication—Letter from the Opponent O4 of Aug. 8, 2025 filed in the Opposition against European Patent No. 2712312, dated Aug. 13, 2025, 10 pages. [cited by applicant]
Brief Communication—Letter from the proprietor of the patent of Aug. 8, 2025 filed in the Opposition against European Patent No. 2712312, mailed on Aug. 14, 2025, 5 pages. [cited by applicant]
Decision of Board of Appeal T 2401/19 Datasheet for the decision of Feb. 5, 2024, 51 pages. [cited by applicant]
Declaration II of Viktoria Skeppstedt filed in the Opposition against European Patent No. 2712312, dated Jul. 1, 2025, 2 pages. [cited by applicant]
Markers of Wound Bed Inflammation, filed in the Opposition against European Patent No. 2712312 on Aug. 8, 2025, 2 pages. [cited by applicant]
Declaration of Dr. Maria Skold filed in the Opposition against European Patent No. 2712312, dated Mar. 2, 2026, 4 pages. [cited by applicant]
Statement of Grounds of Appeal against European Patent No. 2712312, mailed on Mar. 4, 2026, 21 pages. [cited by applicant]
Statement of Grounds of Appeal for European Patent No. 2712312, mailed on Mar. 4, 2026, 9 pages. [cited by applicant]
Statement of Grounds of Appeal for European Patent No. 2712312, mailed on Mar. 6, 2026, 99 pages. [cited by applicant]